KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Total Debt (2016 - 2025)

Edwards Lifesciences has reported Total Debt over the past 17 years, most recently at $598.3 million for Q4 2025.

  • Quarterly results put Total Debt at $598.3 million for Q4 2025, changed 0.1% from a year ago — trailing twelve months through Dec 2025 was $598.3 million (changed 0.1% YoY), and the annual figure for FY2025 was $598.3 million, changed 0.1%.
  • Total Debt for Q4 2025 was $598.3 million at Edwards Lifesciences, roughly flat from $598.2 million in the prior quarter.
  • Over the last five years, Total Debt for EW hit a ceiling of $598.3 million in Q4 2025 and a floor of $595.2 million in Q1 2021.
  • Median Total Debt over the past 5 years was $596.8 million (2023), compared with a mean of $596.8 million.
  • Biggest five-year swings in Total Debt: increased 0.12% in 2021 and later increased 0.1% in 2025.
  • Edwards Lifesciences' Total Debt stood at $595.7 million in 2021, then grew by 0.1% to $596.3 million in 2022, then rose by 0.12% to $597.0 million in 2023, then increased by 0.12% to $597.7 million in 2024, then rose by 0.1% to $598.3 million in 2025.
  • The last three reported values for Total Debt were $598.3 million (Q4 2025), $598.2 million (Q3 2025), and $598.0 million (Q2 2025) per Business Quant data.